90288 Botulism ig intravenous
Also known as: BIG-IV, botulism IG, botulism immunoglobulin
Botulism immunoglobulin intravenous for passive immunotherapy of botulism in pediatric patients.
In Plain Language
infant botulism treatment; immune globulin for botulism
Clinical Context
FDA-approved immunotherapeutic for infantile botulism caused by Clostridium botulinum toxin, administered intravenously to bind and neutralize toxin.
RVU Information
CPT 90288 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Medicine section codes cover a wide range of non-surgical services. Documentation should include the clinical indication, procedure details, interpretation (if applicable), and any patient-specific findings.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Medicine category, 34% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 90288?
CPT 90288 (Botulism ig intravenous) is a Medicine code. Botulism immunoglobulin intravenous for passive immunotherapy of botulism in pediatric patients.
Who uses CPT code 90288?
CPT 90288 is used by Infectious Disease, Pediatrics, Critical Care. FDA-approved immunotherapeutic for infantile botulism caused by Clostridium botulinum toxin, administered intravenously to bind and neutralize toxin.
When is CPT 90288 used?
FDA-approved immunotherapeutic for infantile botulism caused by Clostridium botulinum toxin, administered intravenously to bind and neutralize toxin.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and export board-ready case logs — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.